Abrogation of the G2 checkpoint by inhibitors of Chk1 [74], Wee1 [77], or ATR [78] may therefore selectively sensitize p53 defective cancer cells to DNA damaging agents resulting in cell death by mitotic catastrophe [79], while relatively sparing the surrounding normal p53-proficient cells. This evidence concerns the gene TP53 and cancer.